A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Treatment Resistant Depression

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Noble Clinical Research, Tucson, Arizona, United States

  • Pillar Clinical Research, LLC, Little Rock, Arkansas, United States

  • Preferred Research Partners, Inc., Little Rock, Arkansas, United States

  • Woodland Research Northwest, Rogers, Arkansas, United States

  • CenExel, Garden Grove, California, United States

  • Behavioral Research Specialists, LLC, Glendale, California, United States

  • Kadima Neuropsychiatry Institute, La Jolla, California, United States

  • Collaborative Neuroscience Research, LLC, Los Alamitos, California, United States

  • TRIP Clinical at Psychedelic Science Institute, Santa Monica, California, United States

  • Mountain View Clinical Research Inc., Denver, Colorado, United States

  • CenExel, Hollywood, Florida, United States

  • Bioresearch Partner, Miami, Florida, United States

  • University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa, Florida, United States

  • CenExcel, Decatur, Georgia, United States

  • CenExel, Savannah, Georgia, United States

  • Pillar Clinical Research LLC, Chicago, Illinois, United States

  • Sheppard Pratt, Baltimore, Maryland, United States

  • Sunstone Medical, PC, Rockville, Maryland, United States

  • Elixia MA, Springfield, Massachusetts, United States

  • Adams Clinical, Watertown, Massachusetts, United States

  • Institute for Integrative Therapies, Eden Prairie, Minnesota, United States

  • Midwest Research Group, Saint Charles, Missouri, United States

  • Clinilabs, LLC, Eatontown, New Jersey, United States

  • Bio Behavioral Health, Toms River, New Jersey, United States

  • The Medical Research Network, LLC, New York, New York, United States

  • The Ohio State University, Columbus, Ohio, United States

  • Neuro Behavioral Clinical Research, Inc., North Canton, Ohio, United States

  • Scranton Medical Institute, LLC, Moosic, Pennsylvania, United States

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • Biobehavioral Research of Austin, Austin, Texas, United States

  • InSite Clinical Research, DeSoto, Texas, United States

  • Aim Trials, LLC, Plano, Texas, United States

  • Cedar Clinical Research Inc, Draper, Utah, United States

  • Seattle Neuropsychiatric Treatment Center, Bellevue, Washington, United States

  • Sydney Local Health District (SLHD) Mental Health, Camperdown, New South Wales, Australia

  • Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

  • NeuroCentrix, Carlton, Victoria, Australia

  • The University of Melbourne, Carlton, Victoria, Australia

  • Royal Melbourne Hospital, Melbourne, Victoria, Australia

  • Paratus Clinical Research Melbourne, Northcote, Victoria, Australia

  • Royal Melbourne Hospital Parkville, Parkville, Victoria, Australia

  • University of Melbourne, Parkville, Victoria, Australia

  • Centre for Neurology Studies, Surrey, British Columbia, Canada

  • Providence Care Hospital, Kingston, Ontario, Canada

  • Clerkenwell Health, Doncaster, England, United Kingdom

  • Clerkenwell Health, London, England, United Kingdom

  • NeuroClin, Motherwell, England, United Kingdom

  • Clerkenwell Health, London, United Kingdom